81194 Ntrk translocation analysis
Also known as: NTRK translocation testing, NTRK fusion detection
Molecular analysis to detect NTRK gene rearrangements and translocations (any NTRK partner) associated with various solid malignancies.
In Plain Language
cancer gene test; cancer translocation screening
Clinical Context
Employed to identify NTRK fusions in any solid tumor for determination of NTRK-targeted therapy eligibility across multiple cancer types.
RVU Information
CPT 81194 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81194?
CPT 81194 (Ntrk translocation analysis) is a Pathology & Lab code. Molecular analysis to detect NTRK gene rearrangements and translocations (any NTRK partner) associated with various solid malignancies.
Who uses CPT code 81194?
CPT 81194 is used by Oncology, Pathology, Molecular Medicine. Employed to identify NTRK fusions in any solid tumor for determination of NTRK-targeted therapy eligibility across multiple cancer types.
When is CPT 81194 used?
Employed to identify NTRK fusions in any solid tumor for determination of NTRK-targeted therapy eligibility across multiple cancer types.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.